Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1.59p
   
  • Change Today:
      0.030p
  • 52 Week High: 2.61p
  • 52 Week Low: 0.85p
  • Currency: UK Pounds
  • Shares Issued: 416.44m
  • Volume: 181,321
  • Market Cap: £6.62m
  • RiskGrade: 328

Cash Flow

  £ (Millions) £ (Millions)
Cash Flow Statement 31-Dec-10 31-Dec-09
     
Net Cash Flow From Operating Activities (6.85) 11.96
ROI, Servicing of Finance    
Assocs/JV Dividends Received bn/a bn/a
Interests & Other Dividends Received n/a n/a
Interest Paid bn/a bn/a
Minorities & Non-Equity Divs Paid bn/a bn/a
  n/a n/a
     
Taxation Paid bn/a bn/a
     
Gross Cash Flow bn/a bn/a
     
Capital Expd & Financial Inv    
Interests & Other Dividends Received 0.01 0.06
Disposal of Property, Plant & Equipment n/a n/a
Disposal of Investments n/a n/a
Purchase of Property, Plant & Equipment (0.08) n/a
Purchase of Investments n/a n/a
Net Purchase of Intangible Assets n/a n/a
Other Investing Cash Flow n/a n/a
  (0.07) 0.06
Financing Activities    
Dividends Paid n/a n/a
Repayments of Borrowings (0.03) (0.30)
Borrowings 0.40 0.01
Other Financing Cash Flow 0.19 0.15
  0.56 (0.14)
Net Increase/Decrease In Cash (6.36) 11.88


Key Financials 31-Dec-10 31-Dec-09
     
Shares in Issue - Year End 81.53 81.09
     
Financial Data    
Cash Incr/Decr per Share (7.83p) 15.33p
Operating Cash Flow per Share (8.43p) 15.44p
Gross Cash Flow per Share bn/a bn/a
     
Market Data    
Price/Operating Cash Flow n/a n/a

Key

* GAAP

a. Operating activities before tax

b. Not disclosed under IFRS

c. Not previously included in financing activities

d. Based on operating cash flow before tax

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page